Research Tracker›Biomarker Atlas›ME/CFS›Blood pressure variability

Blood pressure variability in ME/CFS

Blood pressure variability, also described as Beat-to-beat BP, is a autonomic marker reported as elevated in ME/CFS (ME/CFS, CFS) when patients are compared with healthy controls. Clinically, it has been associated with autonomic dysregulation. The evidence summarised here comes from Nelson et al. 2019 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedAutonomic

Summary

Direction in ME/CFS↑ Elevated — higher than in the comparison group
CategoryAutonomic
Also described asBeat-to-beat BP
Compared againstHC (healthy controls)
Associated symptomsAutonomic dysregulation
Test typeClinical or physiological test
SourceNelson et al. 2019 — doi:10.1186/s12967-019-02100-4
Condition atlasME/CFS Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Heart rate (1 registered trials use a matching outcome measure).

Clinical trials using Blood pressure variability as an outcome

Related Autonomic markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is Blood pressure variability high or low in ME/CFS?

Elevated. Studies summarised in the OSMF atlas report higher Blood pressure variability in ME/CFS than in healthy controls. Source: Nelson et al. 2019.

What symptoms is Blood pressure variability associated with in ME/CFS?

The cited literature associates this marker with Autonomic dysregulation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Blood pressure variability?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Blood pressure variability result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. Blood pressure variability findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Blood pressure variability in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/blood-pressure-variability.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.